An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R Inhibitor, in Patients with Relapsed or Refractory Hodgkin Lymphoma. (Q53633582)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R Inhibitor, in Patients with Relapsed or Refractory Hodgkin Lymphoma. |
scientific article |
Statements
An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R Inhibitor, in Patients with Relapsed or Refractory Hodgkin Lymphoma. (English)
1 reference
Bastian von Tresckow
1 reference
Franck Morschhauser
1 reference
Vincent Ribrag
1 reference
Max S Topp
1 reference
Caly Chien
1 reference
Shobha Seetharam
1 reference
Regina Aquino
1 reference
Sonja Kotoulek
1 reference
Carla J de Boer
1 reference
Andreas Engert
1 reference
27 January 2015
1 reference
21
1 reference
8
1 reference
1843-1850
1 reference
Identifiers
1 reference